p53-independent upregulation of p21WAF1 in NIH 3T3 cells malignantly transformed by mot-2

Cell Research

Volumn 11, Issue 1, 2001, Pages 55-60

  Takano, Syuichi ^a,b   Wadhwa, Renu ^c   Mitsui, Youji ^a,b   Kaul, Sunil C ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

cdk 2; Cyclin D1; Malignant transformation; Mot 2; Mouse fibroblasts; p16INK4a; p21WAF1; p53

Indexed keywords

CDK2 PROTEIN, MOUSE; CDKN1A PROTEIN, MOUSE; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; HEAT SHOCK PROTEIN 70; HSPA9B PROTEIN, MOUSE; PROTEIN P53; PROTEIN SERINE THREONINE KINASE;

ANIMAL; ARTICLE; CELL CYCLE; CELL LINE; CELL STRAIN 3T3; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOUSE; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROMOTER REGION; UPREGULATION;

3T3 CELLS; ANIMALS; CDC2-CDC28 KINASES; CELL CYCLE; CELL LINE, TRANSFORMED; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP70 HEAT-SHOCK PROTEINS; MICE; NEOPLASMS; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0035290184     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290066     Document Type: Article

References (46)

1. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88:323-31.
2. Moll UM, Schramm LM. p53-an acrobat in tumorigenesis. Crit Rev Oral Biol Med 1998; 9:23-37.
3. Oren M, Prives C. p53: upstream, downstream and off stream. Biochim Biophys Acta 1996; 1288:R13-9.
4. Cinelli M, Magnelli L, Chiarugi, V. Redundant down-regulation pathways for p53. Pharmacol Res 1998; 37:83-5.
5. Almog N, Rotter V. An insight into the life of p53: a protein coping with many functions. Biochim Biophys Acta 1998; 1378:R43-54.
6. Prives C, Hall PA. The p53 pathway. J Pathol 1999; 187:112-26.
7. Cartel AL, Serfas MS, Tyner AL. p21-negative regulator of the cell cycle. Proc Soc Exp Biol Med 1996; 213:138-49.
8. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 1997; 11:847-62.
9. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA. 1996; 93:13742-47.
10. INK4a. Cell 1997; 88:593-602.
11. INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 1997; 15:203-211.
12. Weinberg RA. The molecular basis of carcinogenesis: understanding the cell cycle clock. Cytokines Mol Ther. 1996; 2:105-10.
13. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211:90-8.
14. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997; 277:831-4.
15. Chang BD, Xuan Y, Broude EV, Zhu H, Schott B, Fang J, Roninson IB. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 1999; 18:4808-18.
16. Fang L, Igarashi M, Leung J, Sugrue MM, Lee SW, Aaronson SA. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene 1999; 18:2789-97.
17. Reddel RR. Genes involved in the control of cellular proliferative potential. Ann N Y Acad Sci 1998; 854:8-19.
18. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995; 82:675-84.
19. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 1995; 377:552-7.
20. Michieli P, Li W, Lorenzi MV, Miki T, Zakut R, Givol D, Pierce JH. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells. Oncogene. 1996; 12:775-84.
21. Michieli P, Basilico C, Ando M, Givol D, Pierce J. (1997) Proc. AACR meeting (tumor suppressor genes) Abstract-B16.
22. Wadhwa R, Takano S, Robert M, Yoshida A, Nomura H, Reddel RR, Mitsui Y, Kaul SC. Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member. J Biol Chem 1998; 273:29586-91.
23. Kaul SC, Duncan EL, Englezou A, Takano S, Reddel RR, Mitsui Y, Wadhwa R. Malignant transformation of NIH3T3 cells by overexpression of mot-2 protein. Oncogene 1998; 17:907-11.
24. Wadhwa R, Kaul SC, Ikawa Y, Sugimoto Y. Identification of a novel member of mouse hsp70 family. Its association with cellular mortal phenotype. J Biol Chem 1993; 268:6615-21.
25. Wadhwa R, Takano S, Mitsui Y, Kaul SC. NIH 3T3 cells malignantly transformed by mot-2 show inactivation and cytoplasmic sequestration of the p53 protein. Cell Res 1999; 9:261-9.
26. Atadja P, Wong H, Garkavtsev I, Veillette C, Riabowol K. Increased activity of p53 in senescing fibroblasts. Proc Natl Acad Sci USA 1995; 92:8348-52.
27. Kaul SC, Wadhwa R, Sugihara T, Obuchi K, Komatsu Y, Mitsui Y. Identification of genetic events involved in early steps of immortalization of mouse fibroblasts. Biochim Biophys Acta 1994; 1201:389-96.
28. WAF1/CIP1 expression by p53-independent pathways. Oncogene 1996; 12:1557-64.
29. Albrecht JH, Meyer AH, Hu MY. Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration. Hepatology 1997; 25:557-63.
30. Hara E, Smith R, Parry D, Tahara H, Stone S, Peters G. Regulation of p16 CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996; 16:859-67.
31. INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene 1997; 15:495-503.
32. INK4A Oncogene 1997; 15: 505-514.
33. Brenner AJ, Stampfer MR, Aldaz CM. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 1998; 17:199-205.
34. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell; 91:649-59.
35. INK4a. Exp Cell Res 1997; 237:7-13.
36. Sugihara T, Kaul SC, Mitsui Y, Wadhwa R. Enhanced expression of multiple forms of VEGF is associated with spontaneous immortalization of murine fibroblasts. Biochim Biophys Acta 1994; 1224:365-70.
37. WAF1/CIP1 expression in pericentral hepatocytes following carbon tetrachloride intoxication. Cell Growth Differ 1997; 8:951-61.
38. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, el-Houseini ME. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 1994; 9:3389-96.
39. Jiang H, Lin J, Su ZZ, Herlyn M, Kerbel RS, Weissman BE, Welch DR, Fisher PB. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene. 1995; 10:1855-64.
40. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996; 10:142-53.
41. Jung JM, Bruner JM, Ruan S, Langford LA, Kyritsis AP, Kobayashi T, Levin VA, Zhang W. Increased levels of p211/Cip1 in human brain tumors. Oncogene 1995; 11:2021-8.
42. Marchetti A, Doglioni C, Barbareschi M, Buttitta F, Pellegrini S, Bertacca G, Chella A, Merlo G, Angeletti CA, Dalla Palma P, Bevilacqua G. p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene. 1996; 12:1319-24.
43. WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection. J Clin Pathol 1998; 51:754-60.
44. WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy. J Urol 1999; 161:792-8.
45. Hiyama H, Iavarone A, LaBaer J, Reeves SA. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene 1997; 14:2533-42.
46. Hiyama H, Iavarone A, Reeves SA. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene 1998; 16:1513-23.